Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Endothelin Receptor Antagonism in Treatment of Coronary Artery Spasm: a Randomized Controlled Clinical Trial

NCT06432452 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT06432452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06432452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Endothelin Receptor Antagonism in Treatment of Coronary Artery Spasm: a Randomized Controlled Clinical Trial
Lead sponsor
Radboud University Medical Center
Phase
Phase 2/3
Overall status
Enrolling by invitation
Start date
November 11, 2024
Completion date
July 1, 2026
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

coronary spasm